Navigation Links
Sosei Group Corporation: Data at ERS Shows Efficacy of Once-daily COPD Portfolio Versus Comparators, Further Establishes Dual-bronchodilator QVA149
Date:9/2/2012

TOKYO, September 3, 2012 /PRNewswire/ --

  • QVA149 demonstrated superior bronchodilation compared to indacaterol 150 mcg, glycopyrronium 50 mcg, salmeterol/fluticasone 50/500 mcg BID, OL tiotropium 18 mcg and placebo[1,2]
  • Seebri® Breezhaler® (glycopyrronium bromide) demonstrated rapid, sustained bronchodilation and reduced exacerbations similar to OL tiotropium 18 mcg in GLOW pooled data analysis[3,4]

Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) highlights that further data from the once-daily chronic obstructive pulmonary disease (COPD) clinical trial programs were presented today by Novartis at the European Respiratory Society (ERS) Congress. Overall, Novartis presented 14 abstracts, including data from the investigational QVA149 (fixed-dose combination of indacaterol maleate / glycopyrronium bromide) IGNITE Phase III clinical trial program, and the glycopyrronium bromide (Seebri® Breezhaler®) GLOW Phase III clinical trial program.

Among the data presented, three new studies from the investigational QVA149 IGNITE Phase III clinical trial program (SHINE, ILLUMINATE and ENLIGHTEN) demonstrated that QVA149 significantly improved lung function compared to other COPD therapies[1,2,6].Data from the GLOW program showed that glycopyrronium 50 mcg once daily provided rapid and sustained bronchodilation, and reduced exacerbations and symptoms when compared to placebo, similar to the levels observed with open-label (OL) tiotropium 18 mcg[3,4].

IGNITE data demonstrated the efficacy of the dual-bronchodilator QVA149 (indacaterol maleate / glycopyrronium bromide) and showed a superior effect on lung function and patient-reported outco
'/>"/>

SOURCE Sosei Group Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
3. Watson to Acquire Actavis Group for EUR4.25 Billion
4. CentraState and Freehold Radiology Group train physicians from China
5. Winner Medical Group Inc. to Host Second Quarter 2012 Earning Conference Call on Thursday, May 10, 2012 at 9:00 p.m. EDT
6. Okuma America Chooses The Daniel Group To Provide Customer Service Research
7. H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group
8. PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor
9. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
10. New Report Outlines Use of Innovative Marketing to Engage Customer Groups that are Key to the Pharmaceutical Industry
11. IntelligentMDx Announces CE-Marking of a new high-throughput test for Group B Streptococcus intended to improve womens health and prenatal care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014 , ... provide insight into treatment and outcomes of patients ... --   Data from nearly 12,500 ... the FIELD-Atrial Fibrillation (GARFIELD-AF), an innovative, independent academic ... for atrial fibrillation (AF) patients remain sub-optimal despite ...
(Date:9/2/2014)... BARCELONA, Spain , September 2, 2014 ... treatment decisions, including patients, quality of life and treatment ... [ 2 ]   ... ESC Congress 2014, 02 September 2014, ... year results of the PREvention oF thromboembolic events-European Registry ...
(Date:9/2/2014)... CHARLOTTE, N.C. , Sept. 2, 2014 /PRNewswire/ ... today announced a partnership with the American Association ... professional association of respiratory care specialists. Edison Nation ... individuals and small business to commercialize their innovation ... professional association,s community of more than 50,000 respiratory ...
Breaking Medicine Technology:Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 2One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 3One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 4One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 5One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 6One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 7One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 8Edison Nation Medical and AARC Team Up To Promote Innovation in Respiratory Care 2Edison Nation Medical and AARC Team Up To Promote Innovation in Respiratory Care 3
... Society of Clinical Oncology,s ... Genitourinary Symposium -, ... (Nasdaq: DNDN ) today presented data,demonstrating the correlation of ... active cellular immunotherapy,for hormone-refractory prostate cancer, with overall survival. This ...
... Confirm the Benefit Avastin Brings to ... Patients With Breast Cancer., BASEL, ... in metastatic breast cancer investigating Avastin,(bevacizumab) in combination with docetaxel chemotherapy ... patients,live without their disease advancing., The findings come from the ...
Cached Medicine Technology:Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival 2Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival 3Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival 4Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 2Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 3
(Date:9/2/2014)... -- Two new studies further confirm the health benefits ... breast-fed have a lower risk of ear, throat and ... finds a similar trend when it comes to allergies. ... in the immediate newborn period," said Dr. Jennifer Wu, ... City. She was not involved in the new studies. ...
(Date:9/2/2014)... -- Melatonin supplements did not reduce delirium in seniors ... found. Many older hospital patients experience the sudden, ... their normal sleep-wake cycle. A lack of the hormone ... but there has been little research into whether melatonin ... 378 patients, average age 84, who had hip fracture ...
(Date:9/2/2014)... leading group of oncologists has released updated guidelines for ... cancer. HER2-negative breast tumors include cancers that ... the American Society of Clinical Oncology (ASCO) explained Tuesday ... of women with advanced breast cancer have HER2-negative tumors, ... aim is to improve both the length and quality ...
(Date:9/2/2014)... By Steven Reinberg ... (HealthDay News) -- As the Ebola outbreak continues to ... experts from the United States and the United Nations ... stem history,s biggest outbreak of the often-fatal virus. ... Disease Control and Prevention, said that without a greater ...
(Date:9/2/2014)... Doctors trained in locations with less intensive (and expensive) ... clinical decisions that spare patients unnecessary and excessive medical ... Internal Medicine . , "Growing concern about the costs ... assessing physicians, ability to avoid the provision of unnecessary ... Outcomes Group and The Dartmouth Institute for Health ...
Breaking Medicine News(10 mins):Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2Health News:New Guidelines for Treating Form of Advanced Breast Cancer 2Health News:More Global Help Needed to Fight Ebola Outbreak 2Health News:More Global Help Needed to Fight Ebola Outbreak 3Health News:Residency training predicts physicians' ability to practice conservatively 2
... , NEW YORK, Aug. 31 You may ... Massapequa, NY is a rare breed. He,s also a rare blood ... dedicated blood donor. , , Make that a VERY ... volunteer whole blood donation, the most on record for New York Blood ...
... FAIRFAX, Va., Aug. 31 The Office of National ... Services (HHS) issued key considerations and challenges for HIE implementation ... Title XIII funding document. , , ... Privacy and security of health information, including ...
... , , PHOENIX, Aug. 31 ... healthcare technology solutions for the ambulatory sector, announced today ... (NHIN), which is being developed to provide a secure, ... others involved in supporting healthcare. Noteworthy was one of ...
... 6 months of age, optometrists say , MONDAY, Aug. ... exam to their children,s back-to-school list, experts say. ... school without ever having an eye examination, even though ... , According to the American Optometric Association,s 2009 survey, ...
... identified a serious and previously misunderstood contaminant that ... into question. In a report published in the ... Leukocyte Biology ( http://www.jleukbio.org ), they show ... blood pressure in ailing patients also contains substances ...
... movie Gattaca, Ethan Hawke stars as a man with "inferior ... future. The 1997 film illustrates the very real fear ... information could be used negatively against us. Last year, ... way DNA data is made publicly available, health institutes in ...
Cached Medicine News:Health News:This Guy's Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations 2Health News:This Guy's Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations 3Health News:This Guy's Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations 4Health News:Edmond Scientific Company Rallies as Certifications & Assessments (C&A) Provider for HIEs Pursuing ARRA-ONC Grants 2Health News:Noteworthy Medical Systems Demonstrates National Health Information Network (NHIN) Interoperability 2Health News:Noteworthy Medical Systems Demonstrates National Health Information Network (NHIN) Interoperability 3Health News:Is Eye Exam on Your Back-to-School List? 2Health News:Are intravenous treatments safe? New research raises doubts 2Health News:Open source DNA 2Health News:Open source DNA 3
More Info Lacrimal Intubation Set. Size: Probes 23g x 7"....
... Robot Stainer HMS 760 X is equipped ... and transferred during program execution. This feature ... system contributes to a significant reduction of ... glass cover and a vapor escape via ...
... Designed for applications in the field of ... also be used as a back-up instrument in ... size and safety clamps for the cover, the ... Boasting an optional 12-volt transformer, it can be ...
... The OTF5000 represents the new style ... long-established and reliable OTF/AS cryostat, the ... systems in the ever-reliable and powerful ... options plus money-saving package deals makes ...
Medicine Products: